{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:02:10Z","timestamp":1772748130431,"version":"3.50.1"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:p>\n                    We presented the imaging findings of\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG and\n                    <jats:sup>68<\/jats:sup>\n                    Ga-HER2 affibody PET\/CT in a 52-year-old woman with HER2-positive accessory breast cancer in the right axilla.\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG and HER2 PET\/CT showed avid uptake of multiple axillary lesions. HER2 PET\/CT identified extensive bone metastases with intense uptake, while the \u2079\u2079\u1d50Tc-MDP whole bone scan was negative, and only a few bone lesions with mild tracer uptake were detected by\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG PET\/CT. Following 6 cycles of the TCbHP regimen, the axillary lesions markedly reduced. This case demonstrates that HER2 PET\/CT enables more sensitive detection of HER2-positive lesions, thereby allowing for precise staging and guiding HER2-targeted therapy.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006305","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T15:00:56Z","timestamp":1768834856000},"page":"362-364","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Ultra-Sensitive Detection of Bone Metastasis From Accessory Breast Cancer Using HER2 PET\/CT: A Case Report"],"prefix":"10.1097","volume":"51","author":[{"given":"Lei","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sijuan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0495-9510","authenticated-orcid":false,"given":"Xiaohua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"key":"R1-20260305","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/000313480407000409","article-title":"Lobular carcinoma in ectopic axillary breast tissue","volume":"70","author":"Giron","year":"2004","journal-title":"Am Surg"},{"key":"R2-20260305","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00266-013-0125-1","article-title":"Ectopic breast cancer: case report and review of the literature","volume":"37","author":"Francone","year":"2013","journal-title":"Aesthetic Plast Surg"},{"key":"R3-20260305","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.suronc.2009.09.005","article-title":"A case of ectopic breast cancer with a literature review","volume":"20","author":"Nihon-Yanagi","year":"2011","journal-title":"Surg Oncol"},{"key":"R4-20260305","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.3892\/ol.2015.3388","article-title":"Diagnosis and treatment of accessory breast cancer in 11 patients","volume":"10","author":"Zhang","year":"2015","journal-title":"Oncol Lett"},{"key":"R5-20260305","doi-asserted-by":"crossref","first-page":"852748","DOI":"10.1155\/2014\/852748","article-title":"Human epidermal growth factor receptor 2 (HER2) in cancers: overexpression and therapeutic implications","volume":"2014","author":"Iqbal","year":"2014","journal-title":"Mol Biol Int"},{"issue":"15","key":"R6-20260305","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.3390\/jcm12154882","article-title":"PET\/CT and SPECT\/CT Imaging of HER2-Positive Breast Cancer.","volume":"12","author":"McGale","year":"2023","journal-title":"J Clin Med"},{"key":"R7-20260305","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.3390\/cancers15071987","article-title":"Emerging targeted therapies for HER2-positive breast cancer","volume":"15","author":"Mercogliano","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R8-20260305","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13058-015-0648-2","article-title":"The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer\u2014a systematic review","volume":"17","author":"Mendes","year":"2015","journal-title":"Breast Cancer Res"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006305","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T21:02:50Z","timestamp":1772744570000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006305","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"assertion":[{"value":"2025-10-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}